Loading stock data…
BYSI
$1.44-0.07 (-4.64%)
BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on the development of cancer therapies.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
BeyondSpring Inc. in the Healthcare sector is trading at $1.44. The stock is currently near its 52-week low of $1.21, remaining 18.2% below its 200-day moving average. Technical signals show neutral RSI of 33 and bearish MACD signal, explaining why BYSI maintains its current current market pressure. The Whystock Score of 45/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Oversold momentum (RSI 33) — potential for technical mean-reversion
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$1.44
Potential Upside
5%
Whystock Fair Value$1.51
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on the development of cancer therapies. It operates through two segments: Plinabulin pipeline and TPD platform. The company's lead asset is the Plinabulin, a selective immunomodul...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$68.26M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.51
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
3.13%
Volume
Today's trading volume
25,940
Recent News
Here's Why We're A Bit Worried About BeyondSpring's (NASDAQ:BYSI) Cash Burn Situation
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Here's Why We're Watching BeyondSpring's (NASDAQ:BYSI) Cash Burn Situation
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Can BeyondSpring (NASDAQ:BYSI) Afford To Invest In Growth?
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...